Trichloroethylene (TCE), commonly used as an industrial solvent, is ubiquitous in our living environment. TCE exposure can induce hepatocellular carcinoma (HCC) in mice, but the underlying mechanisms remain elusive. To understand the role of miRNA in the hepatocarcinogenesis of TCE, we examined the miRNA expression profiles by microarray in the liver of B6C3F1 male mice exposed to TCE at 0 or 1000 mg/kg b.w. Nine differentially expressed miRNAs were identified, out of which miR-182-5p exhibited the highest increase in expression. Moreover, the TCE-induced upregulation of miR182-5p in mouse liver was dose dependent and correlated with promoter DNA hypomethylation. Treatment of mouse liver cell lines (BNL CL.2 and Hepa1-6) with TCE at non-toxic doses (0.1 and/or 0.3 mM) significantly increased the expression level of miR-182-5p accompanied with elevated cell proliferation. The TCE-induced cell proliferation was further found to be mediated by miR-182-5p overexpression. Additionally, tumor suppressor gene Cited2, which was downregulated in TCE exposed mouse liver cells, was proved to be a direct target of miR-182-5p. In conclusion, TCE might up-regulate miR-182-5p expression by DNA hypomethylation, which could suppress Cited2 and improve cell proliferation rate, resulting in liver tumor.
Trichloroethylene (TCE), a volatile organic chemical reagent, has been widely used as an industrial organic solvent and remains to be a common contaminant of air, soil, ground water and food (EPA, 2012; Rusyn et al., 2014) . As liver is one of the main TCE target organs, TCE-induced liver damage has been frequently reported in occupational workers, and TCE exposure is suspected to be associated with an increased risk for liver cancer (EPA, 2012; Hansen et al., 2013) . In animal studies, TCE treatment induces hepatocellular carcinoma (HCC) in mice, but the mechanisms are still unclear (Bradford et al., 2011; Rusyn et al., 2014; Sano et al., 2009) .
In 2012, TCE was categorized as a human carcinogen (class I) by the International Agency for Research on Cancer (IARC) mainly based on the strong association between occupational exposure and kidney cancer (Guha et al., 2012; Kim et al., 2014) . TCE is metabolized by both p450 oxidation and GSH conjugation metabolic pathways. S-(1,2-dichlorovinyl)-L-cysteine (DCVC), a mutagenic metabolite resulting from GSH conjugation, was thought to be responsible for TCE-induced kidney cancer, especially for VHL mutations (Caldwell and Keshava, 2006) . However, trichloroacetic acid (TCA), the major liver metabolite resulting from oxidative reaction, appears to be nonmutagenic, which is in line with the negative mutation of Ras gene in TCEinduced mouse liver tumors (EPA, 2012) . On the other hand, aberrant DNA methylation has been found in the liver of mice exposed to TCE, indicating that epigenetic alterations may play important roles in TCE hepatocarcinogenecity (Jiang et al., 2014; Tao et al., 1999 Tao et al., , 2000 .
Similar to DNA methylation, miRNA regulation is also a well studied epigenetic modification. miRNAs are a group of regulatory RNAs of 19-22 nucleotides that suppress protein translation by binding to the 3 0 -untranslated region (UTR) of their target mRNAs (Hudder and Novak, 2008) . Numerous studies have demonstrated that miRNAs can participate in the regulation of various crucial biological processes such as cell proliferation, apoptosis, and cellular differentiation (Inui et al., 2010; Lema and Cunningham, 2010) . miRNAs are also involved in the development of HCC, and abnormal miRNA expression profiles have been frequently found in clinical HCC samples (Liang et al., 2013; Morishita and Masaki, 2015; Sun et al., 2013) . Moreover, a number of miRNAs have been used as biomarkers for HCC diagnosis and treatment (Chawla et al., 2015; Katayama et al., 2012; Sun et al., 2013) . The aim of this study was to provide epigenetic evidence on the role of miRNAs in TCE hepatocarcinogenesis. We first examined the miRNA expression profiles in the liver of mice exposed to TCE, and then validated the upregulation of miR-182-5p in TCE treated mouse liver cell lines. We further found that DNA hypomethylation might be responsible to the TCE-induced miR-182-5p overexpression which directly represses Cited2 expression and promotes cell proliferation.
MATERIALS AND METHODS
Chemicals. Trichloroethylene (CAS 79-01-6, !99.5% pure) was purchased from Adamas-beta (Shanghai, China). 5-aza-2 0 -deoxycytidine (5-Aza) and TSA were obtained from Solarbio (Beijing, China) and Cell Signaling Technology (Danvers), respectively. All the 3 Chemicals were dissolved in DMSO. Other chemicals were purchased from Sigma-Aldrich (St Louis, Missouri) or Thermo Scientific (Shanghai, China) unless otherwise stated.
Animal experiments. Animal procedures were approved by the Institutional Animal Care/User Ethical Committee of Soochow University (Suzhou, China). Animal care and treatments have been described before (Jiang et al., 2014) . Briefly, B6C3F1 male mice aged 6 weeks were obtained from Model Animal Research Center of Nanjing University (Nanjing, China) and were housed with a 12-h light and 12-h dark cycle at 2262 C temperature.
After 1-week quarantine period, 20 male mice were randomly divided into 4 groups. The mice were orally dosed with TCE at doses of 100, 500 and 1000 mg/kg b.w. in corn oil for 5 days. TCE was freshly dissolved in corn oil each time before administration to prevent vapor release. Control mice were similarly administered with 0.2 ml corn oil. We chose 1000 mg/kg b.w. as the highest dose level based on a previous 2-year carcinogenicity study of TCE in mice (National Toxicology Program, 1990) . Approximately 100 min after the last treatment, the mice were killed and the livers were snap-frozen in liquid nitrogen and stored at À80 C.
Cell culture and treatment. Mouse embryonic liver cell line BNL CL.2, mouse hepatoma cell line Hepa1-6, and human lung cancer cell line A549 were obtained from the Committee of Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). The cells were maintained in Dulbecco's minimum essential medium (DMEM) complemented with 10% fetalbovine-serum and Penicillin-Streptomycin Solution (100 U/ml, Cyclone) at 37 C in a 5% CO 2 atmosphere. For TCE treatment, cells were incubated with DMEM medium containing TCE at different dose levels (0-10 mM) for 48 h (Hong et al., 2013) . For 5-Aza and TSA treatment, cells were cultured in the absence or presence of 5-Aza (5 lM) for 3 days, and TSA (300 nM) was added only for the last 24 h (Jowaed et al., 2010; Noguer-Dance et al., 2010; Yang et al., 2013) .
DNA, RNA and protein extraction. Genomic DNA, RNA and protein were extracted using TIANprep DNA/RNA/Protein Isolation Kit (Tiangen, Beijing, China). Total RNA was isolated by TRNzol-Aþ reagent (Tiangen). The concentration and purity of the isolated DNA and RNA were measured by NanoDrop ND-2000 (Thermo Scientific). Protein concentrations were quantified by BCA determination Kit (Beyotime, China).
Microarray analysis. The Affymetrix GeneChip miRNA 3.0 was used to examine the microRNA expression profiles. The sample labeling, microarray hybridization and washings were performed as described in manufacturer's standard protocols. Agilent Scanner G2505C (Agilent Technologies) was used to get array images which was then analyzed by Feature Extraction software (version10.7.1.1, Agilent Technologies) to get raw data. Genesrping software (version 12.5; Agilent Technologies) was used to proceed data analysis. Differentially expressed miRNAs were identified through fold change as well as P value calculated using t-test. Only miRNAs with a fold change! 2.0 and a P value .05 were considered. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were applied to analyze the roles of the differentially expressed miRNAs. Target genes of differentially expressed miRNAs were predicted based on the intersection of 3 databases (Targetscan, PITA, microRNAorg). GO and KEGG pathway enrichment were analyzed using DAVID (https://david.ncifcrf.gov). The microarray data has been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (accession no.: GSE85904).
Quantitative RT-PCR. Turbo DNA-free TM kit was used to remove genomic DNA contamination. For miRNA expression, firststrand cDNA was synthesized with the miRACLE cDNA synthesis kit (Genetimes Technology, Shanghai, China). For mRNA expression, cDNA was transcribed using RevertAid First Strand cDNA Synthesis Kit. Quantitative PCR (qPCR) was performed on the ABI Prism 7500 system (Applied Biosystems, Foster City) using SYBR selected master mix. As to internal controls, U6 small nuclear RNA was used for miRNA; GAPDH and Ldha were used for mRNA. miRNA primers were brought from Genetimes Technology Inc. mRNA primers were listed in Table 1 . Fold change was calculated using the comparative threshold cycle (Ct) method (2 À᭝᭝Ct ). The experiment was repeated at least 3 times.
Bisulfite sequencing (BSP). Genomic DNA from each mouse liver sample was bisulfite modified using EZ DNA Methylation-Gold Kit (Zymo Research, Orange, California) according to the manufacturer's instruction. The primers used were listed in Table 1 . PCR products of 3 control or TCE treated samples were pooled and cloned into a pGM-T vector (Tiangen). From each plate, at least 10 positive clones selected by blue-white screening were subjected to DNA sequencing using an automatic sequencer (ABI 3730XL).
MTT assay, colony formation assay and EdU labeling. Cells seeded in 96-well plates were treated with DMSO or TCE at various dose levels for 48 h. Cell proliferation was detected by MTT assay (Boster, Wuhan, China) and EdU labeling (Ribobio, Guangzhou, China) according to manufacturer's protocols. For clonogenic assay, cells were replated in 6-well plates and cultured for 2 weeks. Then, the cells were fixed with Carnoy's fluid and stained with 0.4% crystal violet for 5 min. The number of colonies was counted by Gene Box (Syngene, UK).
Comet assay. Cells were seeded in 6-well plates and incubated overnight. After being exposed to different doses of TCE for 48 h, the cells were collected. Cells exposed to ultraviolet for 20 min were used as positive control cells. After being mixed with 0.8% low melt point agarose, cell suspension was planked on a frosted slide which was pre-coated with 1% normal melt point agarose in PBS. The slides were set at 4 C for 20 min and then put into a cylinder with lysis buffer solution (2.5 M NaCl, 0.1 M Na 2 -EDTA, 0.01 M Tris, 1% SDS, 1% Triton-100 and 10% DMSO, adjusted to pH 10.0) for 90 min at 4 C in the dark. The slides were placed into a horizontal electrophoresis tank with fresh electrophoresis liquid (300 mM NaOH, 1 mM Na 2 -EDTA) for DNA unwinding. After 30 min, electrophoresis was operated at 25 V for 30 min in ice water bath. Then, the slides were washed with cold Tris-HCl (pH 7.5) for 3 times and stained with 50 ll Acridine orange solution (1 mg/ml). Pictures were taken by fluorescence microscope (Leica, Germany) and DNA damage was quantified by using CASP software.
Apoptosis analysis by flow cytometry. Apoptosis was examined by using an Annexin V-FITC/PI apoptosis detection kit (Jiamay biotech, China) according to the manufacture's protocol. At least 10 000 events per sample were collected on a FC500 flow cytometry (Becton Dickinson).
miRNA transfection. The miR-182-5p inhibitor, mimic and negative controls were synthesized by Shanghai Integrated Biotech Solutions Co., Ltd. (Shanghai, China). Transfection was performed using transfection reagent Entranster TM -R4000 (Engreen Biosystems, Beijing, China) according to the manufacturer's instruction. After 48 h of transfection, cells were collected for mRNA and protein expression detection.
Western blotting. Samples were subjected to 10% SDS-PAGE gel and then transferred to a PVDF membrane (Merck millionpore, Darmstadt, Germany). The membrane was immediately immersed in 5% BSA in TBS containing 0.1% Tween-20 for 2 h, and then probed with primary antibodies against Cited2 (Proteintech, Wuhan, China) and b-actin (BBI, Shanghai, China) overnight at 4 C. After washing, blots were labeled with HRP-conjugated secondary anti-rabbit antibody. Proteins were developed with enhanced chemiluminescence plus regents and the expression levels were quantified by Gene tools (Syngene, Cambridge, UK).
Luciferase reporter assay. The binding site of miR-182-5p in the 3 0 -UTR of Cited2 mRNA was cloned into the pEZX-MT01 miTarget reporter vector (GeneCopoeia, Rockville) according to the manufacturer's instructions. The mutant binding site was generated using a PCR-based overlap extension method (Sambrook and Russell, 2006) . The primers used are listed in Table 1 . A549 Cells were subsequently co-transfected with vectors containing wild type/mutated Cited2 3 0 -UTR and negative control mimic/miR-182-5p mimic for luciferase assay. Total RNA and protein were collected 48 h after transfection and analyzed using a Luc-Pair miR Luciferase Assay System (GeneCopoeia) according the manufacturer's instructions.
Statistical analysis. Error bars in all the figures represent standard deviation. The statistic methods used were Student's t-test, one-way ANOVA followed by Tukey's or Dunnett's Multiple Comparison Tests. A P value < .05 was considered to be significant.
RESULTS

miRNA-182-5p Expression Is Upregulated in TCE-Treated Mouse Liver
Differentially expressed miRNAs in the liver of mice exposed to TCE at a dose of 1000 mg/kg b.w. for 5 days were screened as shown in Table 2 , Figure 1A and Supplementary Figure 1 , among which 9 miRNAs were selected by volcano plot filtering (fold change ! 2 and P value .05), with 8 up-regulated and one down-regulated. KEGG analysis showed that the predicted target genes of the differentially expressed miRNAs were enriched in cancer pathways (17.2%) and MAPK signaling pathways (11.7%) ( Figure 1B) . The differential expressions of miR-182-5p, miR-34a-5p and miR-451a were validated by qPCR ( Figure 1C ). For miR-182-5p, a dose dependent increase in expression was revealed in the liver of mice exposed to TCE ( Figure 1D ). We further found that miR-182-5p was overexpressed in mouse liver cell lines (BNL CL.2 and Hepa1-6) exposed to TCE at dose levels of 0.1 and 0.3 mM ( Figure 1E ). miR-182-5p in the liver of mice exposed to TCE at different dose levels (1, 100, 500 and 1000 mg/kg b.w.) by qPCR. (E) miR-182-5p expression levels in mouse liver cell lines (BNL CL.2 and Hepa1-6) exposed to TCE at different dose levels (0, 0.03, 0.1 and 0.3 mM). *P < 0.05; **P < 0.01; ***P < 0.001.
miR-182-5p Overexpression Mediates TCE-Induced Liver Cell Proliferation
As shown in Figure 2 , TCE at a high dose level (10 mM) induced cytotoxicity in Hepa1-6 but not in BNL CL.2 cells, while TCE at low dose levels (0.1 and/or 0.3 mM) significantly increased the proliferation rates of the 2 cell lines. As expected, miR-182-5p mimic increased and miR-182-5p inhibitor decreased the cell growth rates (Figure 2 ). Importantly, miR-182-5p inhibitor also aborted the TCE-induced cell proliferation in both cell lines (Figure 2 ). Furthermore, clonogenic assay showed that TCE treatment improved the long-term survival capability of BNL CL.2 (at 0.3 mM) and Hepa1-6 (at 0.1 mM) cell lines (Supplementary Figure 2) . In contrast, DNA damage was only detected in cells exposed to TCE at a high dose level (10 mM), and no apparent apoptosis was found by the treatments (Supplementary Figs. 3  and 4) .
Promoter DNA Hypomethylation Contributes to the TCE-Induced miR-182-5p Overexpression
The DNA methylation levels of 2 segments of the miR-182-5p promoter region decreased in the liver of mice exposed to TCE at 1000 mg/kg b.w. compared with vehicle controls (Figure 3A and B). In addition, 5-Aza (a DNA methyltransferase inhibitor) but not TSA (a histone deacetylase inhibitor) significantly increased the expression level of miR-182-5p in mouse liver cell line BNL CL.2 ( Figure 3C ). On the contrary, the expression level of miR-451a increased in BNL CL.2 cells treated with TSA but not 5-Aza ( Figure 3C ). Overexpression of miR-182-5p was also found in 5-Aza treated Hepa1-6 cell lines ( Figure 3D ).
Tumor Suppressor Gene Cited2 Is a Directly Target of miR-182-5p
Based on our previous mRNA array data (Jiang et al., 2014) , a number of down-regulated mRNAs were found to be miR-182-5p predicted target genes, including Cited2, Med1, Sox17, Dnmt3a and Dnmt3b. The downregulation of Dnmt3a and Dnmt3b has been validated by qPCR in our previous paper (Jiang et al., 2014) . Here we confirmed the downregulation of Cited2, Med1 and Sox17 as shown in Figure 4A . In addition, the transcriptional levels of all the 5 genes (Cited2, Med1, Sox17, Dnmt3a and Dnmt3b) were decreased by TCE in Hepa1-6 cells, while only cited2 and Dnmt3b were downregulated in BNL CL.2 cells ( Figure 4B) .
At the protein level, Cited2 was downregulated in all the TCE-treated mouse liver samples ( Figure 4C ). we further found that the TCE-induced downregulation of the protein expression level of Cited2 was aborted by miR-182-5p inhibitor in mouse liver cell line BNL CL.2, ( Figure 4D ). Luciferase reporter assay showed significantly reduced luciferase activity by miR-182-5p mimic in A549 cells transfected with wild type Cited2 reporter, and mutation of the predicted miR-182-5p binding site completely restored luciferase expression as shown in Figure 4E and F.
DISCUSSION
Epigenetic mechanisms have been suggested to be involved in TCE hepatocarcinogenesis (EPA, 2012) . Alterations of TCEinduced DNA methylation have been reported in mouse liver or liver cell lines (Jiang et al., 2014; Tao et al., 1999 Tao et al., , 2000 Zhang et al., 2014) . In this study, we found evidence that TCE could induce miRNA expression change in mouse liver. Out of the 9 modulated miRNAs, miR-182-5p and miR-183-5p, 2 members of the miR-183 family, were distinctly overexpressed upon TCE treatment. The upregulation of miR-182-5p was further confirmed in TCE exposed mouse liver cell lines. MiR-182-5p is an oncogenic miRNA reported to be overexpressed in various tumors including hepatocarcinoma (Chiang et al., 2013; Liu et al., 2012; Wang et al., 2014) . Moreover, serum miR-182 has been found to be upregulated in HCC, indicating the potential of this miRNA to be served as a diagnostic and prognostic marker (Chen et al., 2015) . DNA methylation has been found to be able to modulate the expression level of miR-182-5p in human melanoma cells ( Liu et al., 2013) . In this study, the promoter region of miR-182-5p was hypomethylated along with its overexpression in the liver of mouse exposed to TCE. As 2 of predicted miR-182-5p target genes, DNA methyltransferase Dnmt3a and Dnmt3b have been shown to be downregulated in the liver of mice exposed to TCE (Jiang et al., 2014) . On the other hand, miR-182 mimic is reported to suppress the expression of DNMT3a in human cervical cancer cell lines (Sun et al., 2015) . Thus, it is possible that the TCE-induced overexpression of miR-182-5p might inhibit Dnmt3a and/or Dnmt3b, which in turn lead to DNA hypomethylation in miR-182-5p promoter region. Our results showed that TCE could promote cell proliferation and colony formation in mouse liver cell lines. Moreover, the increased growth rate of mouse liver cells exposed to TCE was aborted by miR-182-5p inhibitor, indicating that miR-182-5p mediated the TCE-induced cell proliferation. In contrast, TCE at non-cytotoxic dose levels did not induce detectable apoptosis and DNA damage in the 2 mouse liver cell lines. Cell proliferation, as a necessary stage of tumor development, may enhance tumor formation by increasing spontaneous mutations or providing a promotion of spontaneously initiated cells (Feitelson et al., 2015) . It has been reported that increased hepatocyte hyperplasia and liver-to-body weight appeared in TCE treated mouse liver (Ramdhan et al., 2010; Sano et al., 2009) . Thus, the TCE-induced miR-182-5p overexpression may take part in hepatocarcinogenesis by way of promotion in cell proliferation.
Cited2 plays an important role in liver development and functions as a tumor suppressor in liver cells (Cheung et al., 2013; Qu et al., 2007) . A lower mRNA expression level of Cited2 has been found in primary HCC samples compared with adjacent normal tissues (Cheung et al., 2013) . Cited2 knockdown in human liver cells significantly increases cell proliferation and promotes G1-S transition (Cheung et al., 2013) . In this study, we conformed Cited2 as a direct target of miR-182-5p, and its downregulation by miR-182-5p played an important role in TCEinduced cell proliferation of mouse liver.
In conclusion, our data indicates that TCE exposure down-regulates Dnmt3a and Dnmt3b, which results in hypomethylation of the promoter region of miR-182-5p, leading to miR-182-5p overexpression. Up-regulation of miR-182-5p in turn inhibits Cited2, which enhances cell proliferation and consequently promotes TCE hepatocarcinogenesis (see Figure 5 ).
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